79
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Adjunctive Care with Nutritional, Herbal, and Homeopathic Complementary and Alternative Medicine Modalities in Stroke Treatment and Rehabilitation

Pages 30-39 | Published online: 18 Dec 2014

REFERENCES

  • Barnes PM, Powell-Griner E, McFann K, et al. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004;(343):1–19.
  • Buck T, Baldwin CM, Schwartz GE. Influence of worldview on health care choices among persons with chronic pain. J Altem Complement Med. 2005;11(3):561–568.
  • Yeh GY, Davis RB, Phillips RS. Use of complementary therapies in patients with cardiovascular disease. Am J Cardiol. 2006;98(5):673–680.
  • Barringer TA, Kirk JK, Santaniello AC, Foley KL, Michielutte R. Effect of a multivitamin and mineral supplement on infection and quality of life. A ran-domized, double-blind, placebo-controlled trial. Ann Intern Med. 2003;138(5):365–371.
  • Church TS, Earnest CP, Wood KA, Kampert JB. Re-duction of C-reactive protein levels through use of a multivitamin. Am J Med. 2003;115(9):702–707.
  • Blot WI, Li JY, Taylor PR, Guo W, Dawsey SM, Li B. The Linxian trials: mortality rates by vitamin-mineral intervention group. Am J Clin Nutr. 1995;62(6 suppl):1424S–1426S.
  • Huang HY, Caballero B, Chang S, et al. The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Ann Intern Med. 2006;145(5):372–385.
  • Calabrese EJ. Toxicological awakenings: the rebirth of hormesis as a central pillar of toxicology [review]. Toxicol Appl Pharmacol. 2005;204(1):1–8.
  • Calabrese EJ, Baldwin LA. Hormesis: a generalizable and unifying hypothesis. Crit Rev Toxicol. 2001;31: 353–424.
  • Bertani S, Lussignoli S, Andrioli G, et al. Dual effects of a homeopathic mineral complex on carrageenan-induced oedema in rats. Br Homoeopathic J. 1999;88(3):101–105.
  • Mori TA. Omega-3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physiol. 2006;33(9): 842–846.
  • Clark WM, Rinker LG, Lessov NS, Lowery SL, Cipolla MJ. Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke. 2001;32(4):1000–1004.
  • Garcia-Estrada J, Gonzalez-Perez 0, Gonzalez-Castaneda RE, Martinez-Contreras A, Luquin S, de la Mora PG, Navarro-Ruiz A. An alpha-lipoic acid-vita-min E mixture reduces post-embolism lipid peroxidation, cerebral infarction, and neurological deficit in rats. Neurosci Res. 2003;47(2):219–224.
  • Alleva R, Nasole E, Di Donato F, Borghi B, Neuzil J, Tomasetti M. alpha-Lipoic acid supplementation in-hibits oxidative damage, accelerating chronic wound healing in patients undergoing hyperbaric oxygen therapy. Biochem Biophys Res Commun. 2005; 333(2):404–410.
  • Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schutte K, Kerum G, Malessa R. Treat-ment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care. 1999; 22(8):1296–1301.
  • Vasdev S, Gill V, Parai S, Gadag V. Diet supplementation attenuates hypertension in Dahl salt sensitive rats. Mol Cell Biochem. 2005;275(1-2):135–141.
  • Sola S, Mir MQ, Cheema FA., Khan-Merchant N., Menon RG, Parthasarathy S, Khan By. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation. 2005;111(3):343–348.
  • Bitar MS, Wahid S, Pilcher CW., Al-Saleh E., Al-Mulla F. Alpha-lipoic acid mitigates insulin resistance in Goto-Kakizaki rats. Horm Metab Res. 2004;36(8): 542–549.
  • Lee DH, Folsom AR, Harnack L, Halliwell B, Jacobs DR Jr. Does supplemental vitamin C increase cardio-vascular disease risk in women with diabetes? Am J Clin Nutr. 2004;80(5):1194–1200.
  • Marchioli R, Levantesi G, Macchia A, Marfisi RM, Nicolosi GL, Tavazzi L, Tognoni G, Valagussa F. Vitamin E increases the risk of developing heart failure after myocardial infarction: results from the GISSI-Prevenzione trial. J Cardiovasc Med. 2006; 7(5):347–350.
  • Huerta JM, Gonzalez S, Fernandez S, Patterson AM, Lasheras C. Lipid peroxidation, antioxidant status and survival in institutionalised elderly: a five-year longitudinal study. Free Radic Res. 2006;40(6):571–578.
  • Yochum LA, Folsom AR, Kushi LH. Intake of antioxi-dant vitamins and risk of death from stroke in post-menopausal women. Am J Clin Nutr. 2000;72(2): 476–483.
  • Ohara N, Naito Y, Nagata T, Tatematsu K, Fuma SY, Tachibana S, Okuyama H. Exploration for unknown substances in rapeseed oil that shorten survival time of stroke-prone spontaneously hypertensive rats. Ef-fects of super critical gas extraction fractions. Food Chem Toxicol. 2006;44(7):952–963.
  • Sato K, Dohi Y, Kojima M, Miyagawa K, Takase H, Katada E, Suzuki S. Effects of ascorbic acid on ambu-latory blood pressure in elderly patients with refrac-tory hypertension. Arzneimittelforschung. 2006; 56(7):535–540.
  • Ward NC, Croft KD. Hypertension and oxidative stress. Clin Exp Pharmacol Physiol. 2006;33(9):872–876.
  • Verhoef MJ, Lewith G, Ritenbaugh C, Boon H, Fleishman S, Leis A. Complementary and alternative medicine whole systems research: beyond identifi-cation of inadequacies of the RCT. Complement Ther Med. 2005;13(3):206–212.
  • Caspi O, Bell IR. One size does not fit all: aptitude-treatment interaction (ATI) as a conceptual frame-work for outcome research. Part I. What is ATI re-search? J Altem Complement Med. 2004;10(3): 580–586.
  • Caspi O, Bell IR. One size does not fit all: aptitude-treatment interaction (ATI) as a conceptual frame-work for outcome research. Part II. Research designs and their application. J Altem Complement Med. 2004;10(4):698–705.
  • Li Y. A clinical study on haunglian fire-purging mix-ture in treatment of 48 cases of primary hyperten-sion. J Trad Chinese Med. 2005;25(1):29–33.
  • Zeng X, Liu M, Yang Y, Li Y, Asplund K. Ginkgo biloba for acute ischaemic stroke. Cochrane Data-base Syst Rev. 2005;4:CD003691.
  • Liu J. The use of Ginkgo biloba extract in acute ischemic stroke. Explore. 2006;2(3):262–263.
  • Pu F, Mishima K, Egashira N, et al. Post-ischemic treatment with toki-shakuyaku-san (tang-gui-shao-yao-san) prevents the impairment of spatial memory induced by repeated cerebral ischemia in rats. Am J Chin Med. 2005;33(3):475–489.
  • Lee DH, Ha N, Bu YM, Choi HI, Park YG, Kim YB, Kim MY, Kim H. Neuroprotective effect of Buddleja officinalis extract on transient middle cerebral artery occlusion in rats. Biol Pharm Bull. 2006;29(8):1608–1612.
  • Shah ZA, Gilani RA, Sharma P, Vohora SB. Cerebroprotective effect of Korean ginseng tea against global and focal models of ischemia in rats. J Ethnopharmacol. 2005;101(1-3):299–307.
  • Bell IR, Koithan M. Models for the study of whole systems. Integrative Cancer Ther. 2006;5(4):293–307.
  • Gong X, Sucher NJ. Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discov-ery and development. Phytomedicine. 2002;9(5): 478–484.
  • Sun X, Chan LN, Gong X, Sucher NJ. N-methyl-D-aspartate receptor antagonist activity in traditional Chinese stroke medicines. Neurosianals. 2003;12 (1):31–38.
  • Xu X, Zhang S, Zhang L, Yan W, Zheng X. The neuroprotection of puerarin against cerebral is-chemia is associated with the prevention of apoptosis in rats. Planta Med. 2005;71(7):585–591.
  • Cheung ZH, So KF, Lu Q, Yip HK, Wu W, Shan JJ, Pang PK, Chen CF. Enhanced survival and regenera-tion of axotomized retinal ganglion cells by a mix-ture of herbal extracts. J Neurotrauma. 2002; 19(3):369–378.
  • Kim H. Neuroprotective herbs for stroke therapy in traditional eastern medicine. Neurol Res. 2005; 27(3):287–301.
  • Bu Y, Jin ZH, Park SY, et al. Siberian ginseng reduces infarct volume in transient focal cerebral ischemia in Sprague-Dawley rats. Phytother Res. 2005;19(2): 167–169.
  • Chapman EH, Weintraub RJ, Milburn MA, et al. Homeopathic treatment of mild traumatic brain in-jury: a randomized, double-blind, placebo-con-trolled clinical trial. J Head Trauma Rehabil. 1999; 14(6):521–542.
  • Jonas W, Lin Y, Tortella F. Neuroprotection from glutamate toxicity with ultra-low dose glutamate. Neuroreport. 2001;12(2):335–339.
  • Jonas W, Lin Y, Williams A, Tortella F, Tuma R. Treatment of experimental stroke with low-dose glutamate and homeopathic Arnica montana. Perfu-sion. 1999;12:452–462.
  • Jonas WB, Jacobs J. Healing with Homeopathy. The Complete Guide. New York: Warner Books; 1996.
  • Schroder D, Weiser M, Klein P. Efficacy of a homeo-pathic Crataegus preparation compared with usual therapy for mild (NYHA II) cardiac insufficiency: re-sults of an observational cohort study. Eur J Heart Failure. 2003;5(3):319–326.
  • Loeb M, High K. The effect of malnutrition on risk and outcome of community-acquired pneumonia. Respir Care Clin N Am. 2005;11(1):99–108.
  • Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, Garland CF, Giovannucci E. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134(6):1129–1140.
  • Lussignoli S, Bertani S, Metelmann H, et al. Effect of Traumeel S, a homeopathic formulation, on blood-induced inflammation in rats. Complement Ther Med. 1999;7(4):225–230.
  • Zhou Y, Hui X, Li N, Zhuang W, Liu G, Wu T, Wei M, Wu X. Saponins from Chinese Buckeye Seed reduce cerebral edema: metaanalysis of randomized con-trolled trials. Planta Med. 2005;71(11):993–998.
  • Raffoul W, Far MS, Cayeux MC, Berger MM. Nutritional status and food intake in nine patients with chronic low-limb ulcers and pressure ulcers: importance of oral supplements. Nutrition. 2006;22(1): 82–88.
  • Desneves KJ, Todorovic BE, Cassar A, Crowe TC. Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled trial. Clin Nutr. 2005; 24(6):979–987.
  • Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2004;1: CD001321.
  • Frass M, Linkesch M, Banyai S, et al. Adjunctive homeopathic treatment in patients with severe sep-sis: a randomized, double-blind, placebo-controlled trial in an intensive care unit. Homeopathy. 2005;94(2):75–80.
  • Roy R, Tiller W, Bell IR, Hoover MR. The structure of liquid water: novel insights from materials research and potential relevance to homeopathy. Materials Res Innovation. 2005;9(4):557–608.
  • Elia V, Niccoli, M. New physico-chemical properties of extremely diluted aqueous solutions. 1 Therm Analysis Calorimetry. 2004;75: 815–836.
  • Elia V, Niccoli, M. Thermodynamics of extremely diluted aqueous solutions. Ann NY Acad Sci. 1999; 879:241–248.
  • Rey L. Thermoluminescence of ultra-high dilutions of lithium chloride and sodium chloride. Physica A. 2003;323:67–74.
  • Biswas SJ, Khuda-Bukhsh AR. Evaluation of protec-tive potentials of a potentized homeopathic drug, Chelidonium majus, during azo dye induced hepatocarcinogenesis in mice. Indian J Exp Biol. 2004;42(7):698–714.
  • Ruiz-Vega G, Perez-Ordaz L, Proa-Flores P, et al. An evaluation of Coffea cruda effect on rats. Br Homoeopathic J. 2000;89(3):122–126.
  • Ruiz-Vega G, Perez-Ordaz L, Leon-Hueramo 0, Cruz-Vazquez E, Sanchez-Diaz N. Comparative ef-fect of Coffea cruda potencies on rats. Homeopathy. 2002;91:80–84.
  • Ruiz G, Torres IL. Homeopathic effect on the sleep pattern of rats. Br Homoeopathic J. 1997;86:201–206.
  • Sukul A, Sinhabau SP, Sukul NC. Reduction of alco-hol induced sleep time in albino mice by potentized Nux vomica prepared with 90% ethanol. Br Homoeopathic J. 1999;88(2):58–61.
  • Sukul NC, Bala SK, Bhattacharyya B. Prolonged cataleptogenic effects of potentized homoeopathic drugs. Psychopharmacology. 1986;89:338–339.
  • Sukul NC, Ghosh S, Sinhababu SP. Reduction in the number of infective Trichinella spiralis larvae in mice by use of homeopathic drugs. Forschende Komplementarmedizin und Klassische Naturheilkunde. 2005;12(4):202–205.
  • Sukul NC, Ghosh S, Sinhababu SP, et al. Strychnos nux-vomica extract and its ultra-high dilution re-duce voluntary ethanol intake in rats. J Altem Complement Med. 2001;7(2):187–193.
  • Riley D, Fischer M, Singh B, et al. Homeopathy and conventional medicine: an outcomes study compar-ing effectiveness in a primary care setting. J Altem Complement Med. 2001;7(2):149–159.
  • Thompson EA, ReilIly D. The homeopathic approach to symptom control in the cancer patient: a pro-spective observational study. Palliative Med. 2002; 16(3):227–233.
  • Van Wassenhoven M, Ives G. An observational study of patients receiving homeopathic treatment. Ho-meopathy. 2004;93:3–11.
  • Witt C, Keil T, Selim D, Roll S, Vance W, Wegscheider K, Willich SN. Outcome and costs of homoeopathic and conventional treatment strate-gies: a comparative cohort study in patients with chronic disorders. Complement Ther Med. 2005; 13(2):79–86.
  • Witt CM, Luedtke R, Baur R, Willich SN. Homeo-pathic medical practice: long-term results of a co-hort study with 3981 patients. BMC Public Health. 2005;5(1):115. Epub.
  • Bell IR, Lewis DA 2nd, Lewis SE, et al. EEG alpha sensitization in individualized homeopathic treat-ment of fibromyalgia. Int J Neurosci. 2004; 114(9):1195–1220.
  • Bell IR, Lewis DA, Brooks AJ, Lewis S, Baldwin CM, Schwartz GE. Heart rate variability changes in fibromyalgia patients treated with individualized homeopathy. In: 2nd Annual ISSSEEM Research Symposium on Energetic and Spiritual Processes in Healing; 2005; Colorado Springs, CO.
  • Bell IR, Lewis DAI, Schwartz GE, et al. Electroencephalographic cordance patterns distin-guish exceptional clinical responders with fibromyalgia to individualized homeopathic medi-cines. J Altem Complement Med. 2004;10(2):285–299.
  • Hyland ME, Lewith GT. Oscillatory effects in a ho-meopathic clinical trial: an explanation using com-plexity theory, and implications for clinical practice. Homeopathy. 2002;91(3):145–149.
  • Lewith GT, Watkins AD, Hyland ME, et al. Use of ultramolecular potencies of allergen to treat asth-matic people allergic to house dust mite: double blind randomised controlled clinical trial. Br Med J. 2002;324(7336):520–523.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.